Physician profile
Wesley Perry
NPI 1124065990
$1,524.16
in general payments reported to CMS, 2019-2025
18 companies · $437 in 2025
The $437 reported for 2025 was more than what 77% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.00 · 2022: $371 · 2023: $363 · 2024: $326 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $995.66 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Capstone Ptc Spinal System |
| Boston Scientific Corporation | $88.61 | 2025 | Intracept, Wavewriter Alpha Prime 16 |
| Astrazeneca Pharmaceuticals LP | $80.74 | 2023-2024 | Andexxa |
| Depuy Synthes Sales INC. | $55.95 | 2022 | |
| Ossur Americas, INC. | $39.24 | 2025 | |
| Djo, LLC | $35.43 | 2024 | Cmf |
| Si-Bone, INC. | $27.49 | 2021-2023 | |
| Molnlycke Health Care US, LLC | $22.96 | 2023 | Mepilex Border Post-Op, Mepitel Ag, Mepilex Border Ag |
| Globus Medical, INC. | $21.03 | 2025 | Hedron |
| Catalyst Pharmaceuticals, INC. | $20.65 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.59 | 2022 | |
| Amgen INC. | $19.32 | 2022 | |
| Cerapedics INC. | $18.78 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Neurelis, INC. | $16.65 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.58 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $16.26 | 2023 | Senza |
| Gt Medical Technologies, INC | $14.47 | 2023 | Gammatile |
| Lundbeck LLC | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.